Liberty Health Divestiture according to IR The divestiture of all interest in Liberty Health has been completed. The decision to divest was based on LHS shares representing a non-essential holding for the Company. The divestiture along with CC Pharma’s financial contributions will be included on the upcoming Q3 2019 earnings reports.
Aphria has no knowledge or comment on the allegations facing the former CEO of Liberty Health Science.
Joel Pierce
Investor Relations Administrator
- You'd be surprised at how much useful information you can get from someone (if you'd only ask) who's job it is to answer the questions of investors. Joel is the man.